<DOC>
	<DOCNO>NCT01986283</DOCNO>
	<brief_summary>This study determine relative abuse potential intact chew PF-00345439 ( Oxycodone Extended-Release Capsules ) compare crush oxycodone HCL immediate release ( IR ) tablets placebo administer orally non-dependent , recreational opioid user .</brief_summary>
	<brief_title>Abuse Potential Study PF-00345439</brief_title>
	<detailed_description />
	<mesh_term>Oxycodone</mesh_term>
	<criteria>Healthy male and/or female subject age 18 55 year recreational opioid user NOT dependent opioids . Evidence history clinically significant medical condition . Diagnosis substance and/or alcohol dependence ( exclude caffeine nicotine ) . Has participate , currently participate , seek treatment substanceand/or alcoholrelated disorder ( exclude nicotine caffeine ) . Has positive urine drug screen ( UDS ) exclude tetrahydrocannabinol ( THC ) . Has positive alcohol breath test . Has history condition opioid contraindicate . History sleep apnea past 5 year resolve correct . Other severe acute chronic medical psychiatric condition laboratory abnormality may increase risk associate study participation investigational product administration may interfere interpretation study result . Positive test Hepatitis B , Hepatitis C , HIV . Allergy history hypersensitivity naloxone HCl , oxycodone HCl , opioids , and/or lactose . Any condition possibly affect drug absorption ( eg , gastrectomy ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>Abuse potential</keyword>
	<keyword>PF-00345439</keyword>
	<keyword>drug abuse</keyword>
</DOC>